Rapid Normalization of a Highly Thickened Pericardium by Chemotherapy in a Patient with T‐cell Acute Lymphoblastic Lymphoma [PDF]
, 2008 Fethi Kılıçaslan +6 more
openalex +1 more source
Asia-Pacific Journal of Clinical Oncology, Volume 21, Issue 3, Page 319-327, June 2025.Age and history of lung radiotherapy are overlooked risk factors for Pneumocystis jirovecii pneumonia (PCP) in cancer patients. Prophylaxis appeared to be fully effective. 21‐day mortality rate in the PCP group was 35.4%. Hematologic malignancy and lung cancer patients are at highest risk for mortality.
S. Chatterji +6 more
wiley +1 more source
Intrathecal chemotherapy for the management of lymphoblastic lymphoma in a 4-year-old dog: a case report. [PDF]
Front Vet Sci, 2023 Lyseight FLS, Dupont COC, Cherubini GB.
europepmc +1 more source
Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T‐cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real‐time quantitative polymerase chain reaction (RQ‐PCR) [PDF]
, 2008 Batia Stark +6 more
openalex +1 more source
European Journal of Haematology, Volume 114, Issue 6, Page 938-952, June 2025.ABSTRACT The treatment landscape for relapsed or refractory acute lymphoblastic leukemia (RR ALL) has evolved significantly with the introduction of monoclonal antibodies such as blinatumomab and inotuzumab ozogamicin. These agents have demonstrated remarkable efficacy, achieving high response rates and minimal residual disease (MRD) negativity ...
Antonella Bruzzese +11 more
wiley +1 more source
Prevalence and Risk Factors of L-Asparaginase-Related Thrombosis Among Acute Lymphoblastic Lymphoma Patients in a Resource-Limited Setup of Sub-Saharan Region. [PDF]
Cancer Rep (Hoboken)Abrar Mohammed A +4 more
europepmc +1 more source
T Lymphoblastic Lymphoma Hiding in Mature Plasmacytoid Dendritic Cell Proliferation: A Case Report and Literature Review. [PDF]
Diagnostics (Basel), 2023 Deng C +7 more
europepmc +1 more source
Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery
Advanced Science, Volume 12, Issue 17, May 8, 2025.The Y‐Hydroporator is a microfluidic gene delivery platform designed for allogeneic NK cell‐based immunotherapies. It achieves highly efficient gene delivery while preserving high cell viability and functionality. By producing engineered NK cells with enhanced cytotoxicity, the platform addresses critical limitations of autologous cell therapy ...
Hyelee Kim +6 more
wiley +1 more source
Acute Neurotoxicity in Children Treated for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: A 10-Year Single-Centre Experience. [PDF]
Children (Basel)Kranjčec I +6 more
europepmc +1 more source
Case Report: Treatment of the rare B-cell lymphoblastic lymphoma with scalp lesion using rotation flap. [PDF]
Front Oncol, 2023 Kim T +8 more
europepmc +1 more source